PRESS RELEASE: CLEVEMED ASSISTS AMERICAN MEDICAL ASSOCIATION IN RELEASE OF CPT CODE FOR RECORDING PHYSIOLOGIC TREMOR

VIEW PRESS RELEASE [PDF]

CLEVELAND, OHIO (April 25, 2009) – The American Medical Association (AMA) CPT® Editorial Panel approved the release of Category III CPT code 0199T for physiologic recording of tremor using accelerometer(s) and gyroscope(s), (including frequency and amplitude) including interpretation and report. Cleveland Medical Devices Inc. (CleveMed) has worked diligently with key personnel as well as members of the AMA on the release of the code to cover Kinesia™, a wireless patient worn device for objectively monitoring the severity of movement disorder motor symptoms such as tremor. Implementation date of 0199T is July 1, 2009.

Kinesia is a compact device worn on the hand and wrist of a patient while they complete a video guided upper extremity motor symptom evaluation, similar to evaluations completed during clinical visits. Symptom severity information is wirelessly telemetered to a nearby computer where it is displayed and stored. Tasks completed for evaluating tremor are automatically scored on a 0 to 4 scale, which correlated to the Unified Parkinson’s Disease Rating Scale, the current gold standard in Parkinson’s disease patient evaluation. Currently, Kinesia is the only device on the market that uses accelerometers AND gyroscopes, as defined in the description of the code, for the physiologic recording of tremor.

“Obtaining the Category III CPT code for Kinesia is a critical milestone for our Division of Movement Disorders,” said Hani Kayyali, President of CleveMed. “Not only will it track usage and demonstrate wide-scale effectiveness of Kinesia, the code will benefit the community at large by availing our technology to so many providers and patients”

Category III CPT codes are temporary codes designated for new and emerging technologies. The use of Kinesia will be tracked through the Category III code and that along with establishing clinical efficacy though peer reviewed journal articles are important steps toward this becoming a permanent Category I code.

About CleveMed

CleveMed was founded with the goal of developing innovative telemetry devices for a variety of medical applications. Today, CleveMed is developing and pioneering the use of novel wireless monitoring systems for high growth neurology and rehabilitation applications, including movement disorders and sleep disorders. Through these innovations, CleveMed has developed a growing range of products that address the needs of the medical, research and academic communities. For more information, please visit www.CleveMed.com

Media Contact

Maureen Phillips Sales & Marketing Manager 216.619.5918 mphillips@GLNeuroTech.com KinetiSense, Kinesia, Kinesia HomeView, BioRadio, CleveLabs, and BioCapture are trademarks of Cleveland Medical Devices Inc. of Cleveland OH provided under license to Great Lakes NeuroTechnologies.


Top